James F. Oliviero
2014
In 2014, James F. Oliviero earned a total compensation of $1.8M as Former Chief Financial Officer at Keryx Biopharmaceuticals, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $146,000 |
|---|---|
| Option Awards | $546,167 |
| Salary | $348,333 |
| Stock Awards | $732,219 |
| Total | $1,772,719 |
Oliviero received $732.2K in stock awards, accounting for 41% of the total pay in 2014.
Oliviero also received $146K in non-equity incentive plan, $546.2K in option awards and $348.3K in salary.
Rankings
In 2014, James F. Oliviero's compensation ranked 5,020th out of 13,032 executives tracked by ExecPay. In other words, Oliviero earned more than 61.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,020 out of 13,032 | 62nd |
Division Manufacturing | 1,789 out of 4,965 | 64th |
Major group Chemicals And Allied Products | 591 out of 1,690 | 65th |
Industry group Drugs | 451 out of 1,369 | 67th |
Industry Pharmaceutical Preparations | 360 out of 1,042 | 66th |
Source: SEC filing on April 15, 2016.
Oliviero's colleagues
We found two more compensation records of executives who worked with James F. Oliviero at Keryx Biopharmaceuticals in 2014.